Acta Medica Iranica 2018. 56(4):278-280.

Novel Homozygous Mutation in the AGPAT2 Gene in a Child With Berardinelli-Seip Congenital Lipodystrophy Syndrome
Ahya Zaridoust, Ali Rabbani, Sima Hosseinverdi, Pascale Hilbert, Nima Rezaei


Berardinelli-Seip congenital lipodystrophy (BSCL) is an autosomal recessive disorder, characterized by the generalized absence of subcutaneous fat and muscular hypertrophy. Meanwhile other signs and symptoms have already been reported with this genetic disorder. Herein, we report an infant with BSCL, who was referred to our center because of acromegaloid and muscular appearance from the age of three months. He had dark skin, hypertrichosis prominent subcutaneous vessels and organomegaly in physical examination. Genetic study showed novel homozygous mutations in the AGPAT2 gene, which confirmed diagnosis of BSCL in this patient. Although clinical suspicious could help us to make diagnosis of congenital disorders, definite diagnosis relies on genetic studies.



Berardinelli-Seip syndrome; Congenital lipodystrophy

Full Text:



Lionel van Maldergem; Berardinelli-Seip congenital Lipodystrophy; Gene Reviews™ [Internet]. (Accessed January 2018, 18, at

Faria CA, Moraes RS, Sobral-Filho DC, Rego AG, Baracho MF, Egito ES, et al. Autonomic modulation in patients with congenital lipodystrophy (Berardinelli- Seip syndrome). Europace 2009;11:763-9.

Pantabee Z. Diabetes mellitus, Constantin Polychronakos. In: Sarafoglou K, Hoffmann GF, Roth KS, eds. Pediatric Endocrinology and Inborn errors of metabolism. 1st ed. New York: McGraw-Hill Education, 2008:268.

Styne DM, Crumbach MM. Puberty: Ontogeny, Neuroendocrinology, Physiology and disorders. In: Melmed S, Polonsky K, Larsen RP, Kronenberg H, eds. Williams textbook of endocrinology. 12th ed. Philadelphia: Saunders, 2011:1075.

Sameer I Dal, Hitesh Patel. Berardinelli - Seip syndrome. Online J Health Allied Sci 2010;9:1-3.

Hegele RA, Joy TR, Al-Attar SA, Rutt BK. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 2007;48:1433-44.

Simha V. Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy. Endocrinol Metab 2014;9:205-12.

Ken Ebihara, Toru Kusakabe, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, et al. Efficacy and safty of Leptin-replacement Therapy and Possible Mechanisms of Leptin Actions in Patients with Generalized Lipodystrophy. JCEM 2007;92:532-41.

Kim CA, Delepine M, Boutet E, El Mourabit H, Le Lay S, Meier M, et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 2008;93:1129-34.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.